首页> 外国专利> VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE

VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE

机译：VHR蛋白质酪氨酸磷酸酶抑制剂，组合物和使用方法

页面导航

摘要
著录项
相似文献

摘要

Disclosed herein are Vaccinia H1-related (VHR) protein tyrosine phosphatase (PTP) inhibitors that provide a method for treating cancer.

机译：本文公开了牛痘相关的（VHR）蛋白酪氨酸磷酸酶（PTP）抑制剂，提供了治疗癌症的方法。 展开▼

著录项

公开/公告号US2009105254A1

专利类型

公开/公告日2009-04-23

原文格式PDF

申请/专利权人 TOMAS MUSTELIN;LUTZ TAUTZ;
展开▼

申请/专利号US20080253804

发明设计人 TOMAS MUSTELIN;LUTZ TAUTZ;
展开▼

申请日2008-10-17

分类号A61K31/427;A61P35;C07D417/06;A61K31/5377;A61K31/454;A61K31/426;

国家 US

入库时间 2022-08-21 19:34:51

相似文献

专利

外文文献

中文文献

1. 蛋白质酪氨酸磷酸酶抑制剂和其使用方法 [P] . 中国专利： CN112955438A . 2021-06-11

2. 甲钴胺及结构类似物在蛋白质酪氨酸磷酸酶SHP-1抑制剂中的应用 [P] . 中国专利： CN102793714A . 2012-11-28

3. VHR protein tyrosine phosphatase inhibitors, compositions and methods of use [P] . 美国专利： US8188080B2 . 2012-05-29

机译： VHR蛋白酪氨酸磷酸酶抑制剂，组合物和使用方法

4. Use of protein tyrosine phosphatase and human growth hormone inhibitors, use of igf1 and a protein tyrosine phosphatase inhibitor and pharmaceutical combination composition for the treatment of muscle atrophy and related disorders [P] . BRPI0819703A2 . 2015-06-16

机译：蛋白质酪氨酸磷酸酶和人类生长激素抑制剂的用途，igf1和蛋白质酪氨酸磷酸酶抑制剂的用途以及药物组合物用于治疗肌肉萎缩和相关疾病

5. Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48 [P] . 美国专利： US7115624B1 . 2006-10-03

机译：抑制蛋白酪氨酸磷酸酶1B和/或T细胞蛋白酪氨酸磷酸酶4和/或其他PTP酶在48位具有Asp残基的方法

1. Total Synthesis of (±)-Nocardione A and (±)-Nocardione B,Two Cdc25B Tyrosine Phosphatase Inhibitors [J] . 中国化学快报（英文版） . 2001,第010期

2. A New VHR Dual-Specificity Protein Tyrosine Phosphatase Inhibitor from Dendrobium moniliforme. [J] . Bae EY, Oh H, Oh WK, Planta medica: Natural products and medicinal plant research . 2004,第9期

3. The VHR dual-specificity protein tyrosine phosphatase (DS-PTPase) inhibitor isolated from Gastrodia elata [J] . Myung Sun Lee, Won Keun Oh, Eun Young Bae, Korean Journal of Food Science and Technology . 2002,第3期

4. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. [J] . Sodeoka M, Sampe R, Kojima S, Journal of Medicinal Chemistry . 2001,第20期

5. Actinodaphnine and Rutacridone as New T-Cell Protein Tyrosine Phosphatase Inhibitors for Drug Development of Obesity [C] . Y Fitrianingrum, D Indarto, R Kusumawati Annual Basic Science International Conference . 2019

6. Methods toward the development of protein tyrosine phosphatase inhibitors. [D] . Chen, Yen Ting. 2004

7. Cutting Edge: Selective Tyrosine Dephosphorylation of Interferon-Activated Nuclear STAT5 by the VHR Phosphatase [O] . Richard Hoyt, Wei Zhu, Fabio Cerignoli, -1

8. Extracellular Regulated Kinases (ERK) 1 and ERK2 Are Authentic Substrates for the Dual-specificity Protein-tyrosine Phosphatase VHR [O] . Jacob L. Todd, Kirk G. Tanner, John M. Denu 1999

1. Receptor-type protein tyrosine phosphatases in cancertype protein tyrosine phosphatases in cancer [J] . Yu Du ,Jennifer R.Grandis . 癌症 . 2015,第2期

2. Structural Insight into the Design on Oleanolic Acid Derivatives as Potent Protein Tyrosine Phosphatase 1B Inhibitors [J] . SHI Jian-Cheng ,TU Wen-Tong ,LUO Min . 结构化学 . 2017,第007期

3. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance [J] . . 中国药理学通报 . 2015,第B11期

4. Screening the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34^(cdc2) kinase [J] . 杨骅 ,郑树 ,MEIJER Laurent . 浙江大学学报（英文版）B辑：生物医学与生物技术 . 2005,第7期

5. 水合物组合型抑制剂抑制性能的研究 [C] . 戴兴学 ,梁德青 ,杜建伟 . 中国工程热物理学会工程热力学与能源利用2009年学术会议 . 2009

6. 模拟空间环境诱导的氧化损伤、骨丢失抑制剂的筛选及G-B-R组合物的防护活性研究 [A] . 卢静 . 2013